OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 66 citing articles:

Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives
Molly Bekbolatova, Jonathan Mayer, Chi Wei Ong, et al.
Healthcare (2024) Vol. 12, Iss. 2, pp. 125-125
Open Access | Times Cited: 113

Future of Artificial Intelligence (AI) - Machine Learning (ML) Trends in Pathology and Medicine
Matthew G. Hanna, Liron Pantanowitz, Rajesh Dash, et al.
Modern Pathology (2025) Vol. 38, Iss. 4, pp. 100705-100705
Open Access | Times Cited: 4

The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Mayur Suresh Gawande, N. N. Zade, Praveen Kumar, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 2

The Artificial Intelligence-Driven Pharmaceutical Industry: A Paradigm Shift in Drug Discovery, Formulation Development, Manufacturing, Quality Control, and Post-Market Surveillance
Kampanart Huanbutta, Kanokporn Burapapadh, Pakorn Kraisit, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106938-106938
Open Access | Times Cited: 11

Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 7

Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 7

Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 7

Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches
Ke Wu, Soon Hwan Kwon, Xuhan Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13121-13121
Open Access | Times Cited: 6

Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13

Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Agyemang Kwasi Sampene, Fatuma Nyirenda
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5

Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 2
Igor Petrušić, Chia‐Chun Chiang, David García‐Azorín, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access

AI-driven antimicrobial peptides for drug development
Y. K. Arora, H. B. Lalwani, Ajay Kumar, et al.
Methods in microbiology (2025)
Closed Access

How much can we save by applying artificial intelligence in evidence synthesis? Results from a pragmatic review to quantify workload efficiencies and cost savings
Ṣẹ̀yẹ Abògúnr̀in, Jeffrey M. Muir, Cristiano A. F. Zerbini, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Artificial Intelligence, Machine Learning, and the Revival of Big Data in Pharmaceutical Sciences
Raveendra Babu Gudimitla, Medarametla Kishore Babu, Sasidhar Bhimana, et al.
IGI Global eBooks (2025), pp. 275-310
Closed Access

Deep learning: A game changer in drug design and development
Sushanta Kumar Das, Rahul Mishra, Amit Samanta, et al.
Advances in pharmacology (2025)
Closed Access

Challenges for Ethics Review Committees in Regulating Medical Artificial Intelligence Research
Alireza Esmaili, Amirhossein Rahmani, Abolhasan Alijanpour, et al.
Indian Journal of Surgical Oncology (2025)
Closed Access

Artificial intelligence in personalized medicine: transforming diagnosis and treatment
Esther Ugo Alum, Okechukwu Paul-Chima Ugwu
Deleted Journal (2025) Vol. 7, Iss. 3
Open Access

Harnessing machine learning for rational drug design
Sandhya Chaudhary, Kalpana Pravin Rahate, Sachin Mishra
Advances in pharmacology (2025)
Closed Access

AI Revolution in Biomedicine and Biotechnology Transformative Trends and Emerging Applications
Manjunatha Badiger, Jose Alex Mathew, Aslam B. Nandyal, et al.
Advances in computational intelligence and robotics book series (2025), pp. 125-146
Closed Access

Artificial intelligence and its applications in agriculture: A review
Peddi Naga Harsha Vardhan, Akhila Badavath, P. Srivalli
Environment Conservation Journal (2025) Vol. 26, Iss. 1, pp. 274-280
Open Access

Artificial intelligence and its application in clinical microbiology
Assia Mairi, Lamia Hamza, Abdelaziz Touati
Expert Review of Anti-infective Therapy (2025)
Closed Access

Smart science: How artificial intelligence is revolutionizing pharmaceutical medicine
B V Swapna, Shibani Shetty, Manjunath Shetty, et al.
Acta Marisiensis. Seria Medica (2024) Vol. 70, Iss. 1, pp. 8-15
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top